Poly Medicure Valuation
| POLYMED Stock | 2,692 72.10 2.61% |
At this time, the company appears to be overvalued. Poly Medicure Limited holds a recent Real Value of USD2265.11 per share. The prevailing price of the company is USD2691.8. Our model determines the value of Poly Medicure Limited from analyzing the company fundamentals such as Shares Outstanding of 101.33 M, operating margin of 0.22 %, and Return On Equity of 0.15 as well as examining its technical indicators and probability of bankruptcy.
Price Book 11.74 | Enterprise Value 293.2 B | Enterprise Value Ebitda 60.671 | Price Sales 18.397 | Trailing PE 90.2645 |
Overvalued
Today
Please note that Poly Medicure's price fluctuation is very steady at this time. Calculation of the real value of Poly Medicure Limited is based on 3 months time horizon. Increasing Poly Medicure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Poly stock is determined by what a typical buyer is willing to pay for full or partial control of Poly Medicure Limited. Since Poly Medicure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Poly Stock. However, Poly Medicure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2691.8 | Real 2265.11 | Hype 2690.56 | Naive 2783.36 |
The real value of Poly Stock, also known as its intrinsic value, is the underlying worth of Poly Medicure Limited Company, which is reflected in its stock price. It is based on Poly Medicure's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Poly Medicure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Poly Medicure Limited helps investors to forecast how Poly stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Poly Medicure more accurately as focusing exclusively on Poly Medicure's fundamentals will not take into account other important factors: Poly Medicure Cash |
|
Poly Medicure Total Value Analysis
Poly Medicure Limited is at this time expected to have takeover price of 293.22 B with market capitalization of 280.09 B, debt of 1.74 B, and cash on hands of 1.76 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Poly Medicure fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
293.22 B | 280.09 B | 1.74 B | 1.76 B |
Poly Medicure Investor Information
About 67.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 30.62. Poly Medicure Limited last dividend was issued on the 19th of September 2024. The entity had 2:1 split on the 24th of March 2017. Based on the measurements of operating efficiency obtained from Poly Medicure's historical financial statements, Poly Medicure Limited is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 2.8 B | 2.7 B |
|
| |||||
| Operating Income | 6.5 B | 6.2 B |
|
|
Poly Medicure Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Poly Medicure has an asset utilization ratio of 74.02 percent. This indicates that the Company is making USD0.74 for each dollar of assets. An increasing asset utilization means that Poly Medicure Limited is more efficient with each dollar of assets it utilizes for everyday operations.Poly Medicure Ownership Allocation
Poly Medicure owns a total of 101.33 Million outstanding shares. Poly Medicure holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.3 pct. of Poly Medicure Limited outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Poly Medicure Profitability Analysis
The company reported the revenue of 13.76 B. Net Income was 2.58 B with profit before overhead, payroll, taxes, and interest of 7.06 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Poly Medicure's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Poly Medicure and how it compares across the competition.
About Poly Medicure Valuation
The stock valuation mechanism determines Poly Medicure's current worth on a weekly basis. Our valuation model uses a comparative analysis of Poly Medicure. We calculate exposure to Poly Medicure's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Poly Medicure's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 4.1 B | 2.7 B |
Poly Medicure Quarterly Retained Earnings |
|
Complementary Tools for Poly Stock analysis
When running Poly Medicure's price analysis, check to measure Poly Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poly Medicure is operating at the current time. Most of Poly Medicure's value examination focuses on studying past and present price action to predict the probability of Poly Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poly Medicure's price. Additionally, you may evaluate how the addition of Poly Medicure to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |